Gentronix
Chris joined Gentronix in 2013 and is the Senior Study Director within the business. Chris has 45 years’ experience in Genetic Toxicology having previously worked for leading global pharmaceutical and R&D companies. Initially joining Gentronix to introduce the Bacterial Reverse Mutation Assay (Ames test) and implementation of GLP compliance in the organisation; Chris now provides expert training, guidance and mentoring to Study Directors within the company as well as leading the Ames testing activities.
This person is not in any offices
Gentronix
Gentronix provides services for the development of drugs and other chemicals in the cosmetics and personal care sectors.